Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement (Exact Sciences)

Exact Sciences unveiled data on the Cologuard Plus™ test at the American College of Gastroenterology (ACG) 2024 Annual Meeting, showcasing its effectiveness as a noninvasive colorectal cancer (CRC) screening tool. Cologuard Plus was highlighted for achieving the highest life-years gained while requiring fewer colonoscopies compared to other noninvasive screening methods. Through a validated simulation model, researchers found that Cologuard Plus provided the best balance of benefits (life-years gained) and burdens (number of colonoscopies) in CRC screening across various age ranges, from 45 to 75 years.